Page 146 - Intersurgical Product Catalogue UK Edition15A
P. 146

146
Nebuliser Therapy • Nebulisers
Choosing a nebuliser
Particles smaller than 0.5 microns expired back to atmosphere
Oral cavity
Particles above 5–10 microns impact on the upper respiratory tract
Nasal cavity
Pharynx Larynx Trachea
Micro CirrusTM alveolar deposition (0.5–2μm)
HOT TopTM2 Tracheobronchial deposition (2–5μm) high speed nebulisation for greater patient compliance
CirrusTM2 Tracheobronchial deposition (2–5μm)
10 66
10 88 44
Tracheobronchial deposition
22
10 10 88
Alveolar deposition
Micro Cirrus nebuliser
The Micro Cirrus has been speci cally designed to create a small particle aerosol with a MMD of 1.2 microns.
At a driving gas  ow of 8 L/min 90% of the particles will be less than 2 microns in diameter.
66 44
22
HOT TopTM2 nebuliser
The HOT Top2 is designed for high speed nebulisation, signi cantly reducing treatment time compared with conventional nebulisers.
At a driving gas  ow of 8 L/min, 80% of the volume output will be particles of less than 5 microns in diameter with a Mass Median Diameter (MMD) of 3 microns.
CirrusTM2 nebuliser
The Cirrus2 has been designed to minimise the residual volume and reduce drug wastage.
At a driving gas  ow of 8 L/min, 74% of the volume output will be particles less than 5 microns in diameter with a MMD of 3.3 microns.
Nebuliser Therapy Training Video available at www.intersurgical.co.uk
Intersurgical • Quality, innovation and choice


































































































   144   145   146   147   148